ClinicalTrials.gg

Drug

Bintrafusp alfa clinical trials

Also written M7824 and MSB0011359C.

studies test it
46
open now
2
in phase 3
3
first study started
2015

Keep track of what changes. Save the bintrafusp alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Development codes

Combined with it in one product

Studies by the year they started

46 studies that test it; most in 2020 (16)

Studies that test bintrafusp alfa, by start year
YearStudies
20151
20161
20189
20194
202016
202112
20222
20241

By phase

A phase 1/2 study counts in both.

Phase 1
22
Phase 2
34
Phase 3
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 12 · Other 34

National Cancer Institute (NCI) (14) · M.D. Anderson Cancer Center (10) · EMD Serono Research & Development Institute, Inc. (10) · Institut Bergonié (1) · Fundación GECP (1) · Merck KGaA, Darmstadt, Germany (1) · The University of Hong Kong (1) · Yonsei University (1)

Often tested with

Tested in the same studies.

Paclitaxel (3) · Carboplatin (3) · Immunocytokine NHS-IL12 (2) · Cisplatin (2) · Gemcitabine (2) · Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 (1) · INCB057643 (1) · Albumin-Bound Paclitaxel (1)

Studies

Open first, then newest update. How each study uses bintrafusp alfa is read from its arms, and is right about nine times in ten.

Testing it · 46

See all 46 studies that test bintrafusp alfa →

Given in every arm · 10 — bintrafusp alfa is usual care beside what is tested

Codes

What other systems call bintrafusp alfa · ClinicalTrials.gg INT017419

  • UNII (FDA) NW9K8C1JN3BINTRAFUSP ALFAOne source FDA
  • NCI Thesaurus C124229Bintrafusp AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.